Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer

We used KRAS mutations to investigate the clinical relevance of circulating tumor DNA (ctDNA) measurements in patients with advanced pancreatic cancer. Fifty‐three blood samples were collected from 14 prospectively recruited patients prior to chemotherapy (gemcitabine or FOLFIRINOX) and subsequently...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Mol Oncol
Autores principales: Tjensvoll, Kjersti, Lapin, Morten, Buhl, Tove, Oltedal, Satu, Steen-Ottosen Berry, Katrine, Gilje, Bjørnar, Søreide, Jon Arne, Javle, Millind, Nordgård, Oddmund, Smaaland, Rune
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2015
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5423145/
https://ncbi.nlm.nih.gov/pubmed/26725968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2015.11.012
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares